Activation of TrkB receptors by NGFβ mimetic peptide conjugated polymersome nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 3, 2012, Pages 271-274

  Soumen, Roy ^a   Johnston, A H ^b   Moin, Syed Tarique ^c   Dudas, Jozsef ^a   Newman, T A ^d   Hausott, Barbara ^a   Schrott Fischer, Anneliese ^a   Glueckert, Rudolf ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF KARACHI   (Pakistan)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Nanoparticle based receptor targeting; Polymersomes; SHSY cells; Trk B activation

Indexed keywords

CELL LINES; GROWTH FACTOR; GROWTH FACTOR DELIVERY; IN-VITRO; IN-VIVO; MULTI-FUNCTIONAL NANOPARTICLES; NEURODEGENERATIVE DISORDERS; NEURONAL CELL; NEUROTROPHIC; NEUROTROPHIN RECEPTOR; POLYMERSOMES; RECEPTOR TARGETING; RETENTION TIME; THERAPEUTIC TARGETS; TYROSINE KINASE;

AMINO ACIDS; BIOMIMETICS; CELL CULTURE; ENZYMES; NANOPARTICLES; NEURODEGENERATIVE DISEASES; PEPTIDES; POLYETHYLENE GLYCOLS;

CHEMICAL ACTIVATION;

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NANOPARTICLE; NERVE GROWTH FACTOR BETA SUBUNIT; POLYMERSOME NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CONJUGATION; CONTROLLED STUDY; DRUG CONJUGATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR INTERACTION; PARTICLE SIZE; SIGNAL TRANSDUCTION;

BIOMIMETIC MATERIALS; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; LACTONES; LIGANDS; MICROSCOPY, CONFOCAL; MODELS, MOLECULAR; NANOPARTICLES; NERVE GROWTH FACTOR; PEPTIDES; POLYETHYLENE GLYCOLS; RECEPTOR, TRKB;

EID: 84858619102     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.12.005     Document Type: Article

References (16)

1. Bibel M., Barde Y.A. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000, 14:2919-2937.
2. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001, 24:677-736.
3. Berkemeier L.R., Winslow J.W., Kaplan D.R., Nikolics K., Goeddel D.V., Rosenthal A. Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 1991, 7:857-866.
4. Soppet D., Escandon E., Maragos J., Middlemas D.S., Reid S.W., Blair J., et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 1991, 65:895-903.
5. Tapia-Arancibia L., Aliaga E., Silhol M., Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 2008, 59:201-220.
6. Canals J.M., Pineda J.R., Torres-Peraza J.F., Bosch M., Martín-Ibañez R., Muñoz M.T., et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 2004, 24:7727-7739.
7. Muller H.D., Hanumanthiah K.M., Diederich K., Schwab S., Schäbitz W.R., Sommer C. Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain. Stroke 2008, 39:1012-1021.
8. Tsukahara T., Takeda M., Shimohama S., Ohara O., Hashimoto N. Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery 1995, 37:733-741.
9. Fritzsch B., Silos-Santiago I., Bianchi L.M., Farinas I. The role of neurotrophic factors in regulating the development of inner ear innervation. Trends Neurosci 1997, 20:159-164.
10. Staecker H., Kopke R., Malgrange B., Lefebvre P., Van de Water T.R. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996, 7:889-894.
11. He X.L., Garcia K.C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004, 304:870-875.
12. Roy S., Johnston A.H., Newman T.A., Glueckert R., Dudas J., Bitsche M., et al. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery. Int J Pharm 2010, 390:214-224.
13. Brodeur G.M., Minturn J.E., Ho R., Simpson A.M., Iyer R., Varela C.R., et al. Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res 2009, 15:3244-3250.
14. Nishida Y., Adati N., Ozawa R., Maeda A., Sakaki Y., Takeda T. Identification and classification of genes regulated by phosphatidylinositol 3-kinase- and TRKB-mediated signalling pathways during neuronal differentiation in two subtypes of the human neuroblastoma cell line SH-SY5Y. BMC Res Notes 2008, 1:95.
15. Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999, 401:184-188.
16. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004, 25:1605-1612.